SUBSCRIBERS
Big pharma turns to artificial intelligence to speed up drug discovery process
Add BT as a preferred sourcePublished Sun, Jul 2, 2017 · 09:50 PM
London
THE world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with Glaxo-SmithKline unveiling a new US$43 million deal in the field on Sunday.
Other pharmaceutical giants including Merck & Co, Johnson & Johnson and Sanofi are also exploring the potential of artificial intelligence (AI) to help streamline the drug discovery process.
Share with us your feedback on BT's products and services
